HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaona You Selected Research

hepatitis B virus X protein

2/2014Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
11/2013Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
7/2013Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells.
3/2013Hepatitis B virus X protein protects hepatoma and hepatic cells from complement-dependent cytotoxicity by up-regulation of CD46.
12/2012Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
7/2012Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18.
1/2012Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration.
8/2011Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack.
5/2010Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaona You Research Topics

Disease

10Hepatocellular Carcinoma (Hepatoma)
02/2014 - 05/2010
7Neoplasms (Cancer)
01/2022 - 08/2011
5Hepatitis B
09/2015 - 08/2012
4Breast Neoplasms (Breast Cancer)
09/2015 - 08/2012
2Carcinogenesis
11/2013 - 12/2012
1Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2022
1Leukemia
01/2022
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2022
1Bone Diseases (Bone Disease)
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
07/2014
1Hypoxia (Hypoxemia)
05/2014
1Infections
11/2013
1Liver Neoplasms (Liver Cancer)
07/2012

Drug/Important Bio-Agent (IBA)

9hepatitis B virus X proteinIBA
02/2014 - 05/2010
8Proteins (Proteins, Gene)FDA Link
09/2015 - 08/2011
5Oncogene Proteins (Oncogene Protein)IBA
09/2015 - 08/2012
2Messenger RNA (mRNA)IBA
04/2022 - 07/2014
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 01/2022
2ChromatinIBA
01/2022 - 07/2014
2Small Interfering RNA (siRNA)IBA
07/2014 - 12/2012
2S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
07/2014 - 06/2013
2Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
05/2014 - 03/2013
2Complement System Proteins (Complement)IBA
03/2013 - 08/2011
2DNA (Deoxyribonucleic Acid)IBA
09/2012 - 08/2011
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2022
1Ribosomal Proteins (Ribosomal Protein)IBA
04/2022
1Proteasome InhibitorsIBA
01/2022
1trametinibIBA
01/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
09/2015
1Sp1 Transcription FactorIBA
07/2014
1LuciferasesIBA
07/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2014
1matrigelIBA
05/2014
1Hemoglobins (Hemoglobin)IBA
05/2014
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2014
1Fibroblast Growth Factor 8IBA
05/2014
1MicroRNAs (MicroRNA)IBA
11/2013
1Biological ProductsIBA
11/2013
1E2F1 Transcription FactorIBA
06/2013
1Dinoprostone (PGE2)FDA Link
03/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2013
1Long Noncoding RNAIBA
07/2012
1OsteopontinIBA
01/2012
1CalpainIBA
01/2012